| Literature DB >> 26748993 |
Shaolin Du1,2, Wenbin Huang1, Xiulan Zhang3, Jiawei Wang1, Wei Wang1, Dennis S C Lam4.
Abstract
BACKGROUND: The existing literature contains no information regarding inflammatory cytokine expression in unilateral acute primary angle-closure (APAC) affected eyes and fellow eyes with primary angle closure suspect (PACS). To measure levels of various inflammatory cytokines in the aqueous humor (AH) of APAC affected eyes and fellow eyes with a diagnosis of PACS (18 unilateral APAC eyes and 18 fellow eyes with PACS), and determine the underlying correlation between them.Entities:
Mesh:
Substances:
Year: 2016 PMID: 26748993 PMCID: PMC4707003 DOI: 10.1186/s12886-016-0182-8
Source DB: PubMed Journal: BMC Ophthalmol ISSN: 1471-2415 Impact factor: 2.209
Demographic and baseline characteristics of patients
| Characteristics | Subjects of study |
|---|---|
| No. of patients (No. of eyes) | 18 (36) |
| Age, y (mean [SD]) | 63.80 (6.76) |
| Sex (male/female) | 5/13 |
| Laterality of affected eye, right/left | 7/11 |
| Duration of experienced attack, d (median [IQ]) | 5.50 (8.25) |
| No. of glaucoma medications in APAC eyes, n (median [IQ]) | 1.00 (1.00) |
SD standard deviation, IQ inter-quartile
Characteristics of Acute Primary Angle-Closure Eyes and Primary Angle-Closure Suspect Eyes
| Characteristics | Affected eyes, APAC | Fellow eyes, PACS |
|
|---|---|---|---|
| IOP at the day of surgery, mmHg | 19.5 (20.68) | 13.5 (6.0) | 0.008* |
| Axial Length (AL), mm | 22.42 (1.50) | 22.25 (1.26) | 0.138 |
| Anterior Chamber Depth (ACD), mm | 2.24 (0.21) | 2.22 (0.28) | 0.236 |
| Lens Thickness (LT), mm | 5.17 (0.61) | 5.29 (0.67) | 0.244 |
| Vitreous Chamber Depth (VCD), mm | 14.96 (1.35) | 14.91 (1.32) | 0.206 |
Data are expressed as the median (IQ). P-values were obtained from 2-related-samples nonparametric test. * P-value < 0.05 was considered to be significant
Level of cytokines in aqueous humor from APAC eyes and fellow eyes with PACS
| Affected eyes, APAC (pg/ml) | Fellow eyes, PACS (pg/ml) |
| |
|---|---|---|---|
| G-CSF | 1608.42 (13.71; 0.00, 17420.00) | 1.11 (0.00; 0.00, 13.58) | 0.001* |
| IL-6 | 520.24 (14.62; 0.00, 3470.00) | 0.35 (0.00; 0.00, 1.82) | 0.000* |
| IL-8 | 160.37 (23.28; 0.00, 1043.00) | 2.96 (1.09; 0.00, 13.64) | 0.000* |
| MCP-1 | 2537.39 (1507.50; 696.75, 7384.00) | 641.71 (661.50; 281.49, 1051.00) | 0.000* |
| MCP-3 | 9.30 (6.45; 0.00, 50.90) | 2.34 (0.49; 0.00, 7.35) | 0.008* |
| MDC | 38.80 (5.60; 0.00, 268.00) | 10.98 (3.61; 0.00, 50.00) | 0.009* |
| MIP-1β | 23.67 (21.21; 0.00, 63.10) | 3.95 (0.16; 0.00, 21.07) | 0.001* |
| VEGF | 701.60 (120.43; 0.00, 5162.00) | 93.87 (91.01; 0.00, 182.00) | 0.035* |
APAC acute primary angle-closure; PACS primary angle-closure suspect. Granulocyte colony-stimulating factor (G-CSF), interleukin (IL)-6, IL-8, monocyte chemotactic protein (MCP)-1, MCP-3, macrophage-derived chemokine (MDC), macrophage inflammatory protein (MIP)-1β, and vascular endothelial growth factor (VEGF). Data are expressed as the mean (median; range). P-values were obtained from 2-related-samples nonparametric test.* P-value <0.05 was considered to be significant
Fig. 1Differences of cytokines in APAC with PACS. Scatterplots showing distribution levels of G-CSF, IL-6, IL-8, MCP-1, MCP-3, MDC, MIP-1β, and VEGF in aqueous humor from unilateral acute primary angle-closure (APAC) affected eyes and fellow eyes with primary angle-closure suspect (PACS). Two-related-samples nonparametric test was performed between groups, and a significant difference was accepted at P < 0.05. The solid lines indicate median concentrations. In the APAC patients, the levels of G-CSF (P = 0.001), IL-6 (P = 0.000), IL-8 (P = 0.000), MCP-1 (P = 0.000), MCP-3 (P = 0.008), MDC (P = 0.009), MIP-1β (P = 0.001), and VEGF (P = 0.035) in AH samples from unilateral APAC affected eyes were significantly higher than those from fellow eyes with PACS
Correlations among cytokines
| ρ/ | G-CSF | IL-6 | IL-8 | MCP-1 | MCP-3 | MDC | MIP-1β | VEGF |
|---|---|---|---|---|---|---|---|---|
| G-CSF | — | 0.829 | 0.726 | 0.696 | 0.785 | 0.547 | 0.608 | 0.307 |
| IL-6 | 0.000* | — | 0.811 | 0.886 | 0.703 | 0.549 | 0.647 | 0.480 |
| IL-8 | 0.000* | 0.000* | — | 0.785 | 0.715 | 0.647 | 0.841 | 0.512 |
| MCP-1 | 0.000* | 0.000* | 0.000* | — | 0.649 | 0.461 | 0.631 | 0.515 |
| MCP-3 | 0.000* | 0.000* | 0.000* | 0.000* | — | 0.500 | 0.607 | 0.434 |
| MDC | 0.001* | 0.001* | 0.000* | 0.005* | 0.002* | — | 0.461 | 0.250 |
| MIP-1β | 0.000* | 0.000* | 0.000* | 0.000* | 0.000* | 0.005* | — | 0.472 |
| VEGF | 0.068 | 0.003* | 0.001* | 0.001* | 0.008 | 0.141 | 0.004* | — |
Granulocyte colony-stimulating factor (G-CSF), interleukin (IL)-6, IL-8, monocyte chemotactic protein (MCP)-1, MCP-3, macrophage-derived chemokine (MDC), macrophage inflammatory protein (MIP)-1β, and vascular endothelial growth factor (VEGF)
Correlation coefficient (ρ) and P values are calculated by Spearman’s correlation
*Significance level at 5 % (P < 0.0071) by Bonferroni correction for multiple comparisons
Correlations between Cytokines and relevant factors in APAC patients
| Age | IOP | Number of Glaucoma Medications | AL | ACD | LT | VCD | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ρ |
| ρ |
| ρ |
| ρ |
| ρ |
| ρ |
| ρ |
| |
| G-CSF | −0.232 | 0.173 | 0.506 | 0.002* | 0.464 | 0.004* | −0.060 | 0.729 | −0.074 | 0.670 | 0.121 | 0.482 | −0.097 | 0.572 |
| IL-6 | −0.115 | 0.503 | 0.424 | 0.010 | 0.443 | 0.007* | −0.089 | 0.605 | 0.031 | 0.860 | 0.040 | 0.815 | −0.132 | 0.444 |
| IL-8 | −0.143 | 0.406 | 0.375 | 0.024 | 0.439 | 0.007* | −0.198 | 0.246 | 0.056 | 0.743 | 0.004 | 0.980 | −0.201 | 0.239 |
| MCP-1 | −0.097 | 0.573 | 0.291 | 0.085 | 0.285 | 0.092 | −0.110 | 0.523 | 0.040 | 0.817 | −0.002 | 0.989 | −0.140 | 0.414 |
| MCP-3 | −0.127 | 0.460 | 0.420 | 0.011 | 0.347 | 0.038 | −0.040 | 0.816 | 0.005 | 0.977 | 0.177 | 0.300 | −0.108 | 0.531 |
| MDC | −0.261 | 0.125 | 0.201 | 0.240 | 0.131 | 0.445 | −0.411 | 0.013 | 0.193 | 0.259 | −0.182 | 0.288 | −0.364 | 0.029 |
| MIP-1β | −0.166 | 0.335 | 0.387 | 0.020 | 0.395 | 0.017 | −0.130 | 0.450 | 0.003 | 0.985 | 0.029 | 0.865 | −0.126 | 0.463 |
| VEGF | 0.013 | 0.941 | 0.318 | 0.058 | 0.198 | 0.247 | −0.051 | 0.769 | −0.091 | 0.597 | 0.300 | 0.075 | −0.185 | 0.280 |
Relevant factors: Age, intraocular pressure (IOP), Number of Glaucoma Medications, Axial Length (AL), Anterior Chamber Depth (ACD), Lens Thickness (LT), Vitreous Chamber Depth (VCD) and Choroidal Thickness in the Macular Region (CT)
Granulocyte colony-stimulating factor (G-CSF), interleukin (IL)-6, IL-8, monocyte chemotactic protein (MCP)-1, MCP-3, macrophage-derived chemokine (MDC), macrophage inflammatory protein (MIP)-1β, and vascular endothelial growth factor (VEGF)
Correlation coefficient (ρ) and P values are calculated by Spearman’s correlation
*Significance level at 5 % (P < 0.0071) by Bonferroni correction for multiple comparisons